Fundraising FoxElysium Therapeutics
Danville, US · Founded 2013 · Delaware corporation
Find your way into Elysium Therapeutics
Sign up to see every warm intro you have to Elysium Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Elysium Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
KL
Kathy LaPorteNamed on SEC filing
AG
Alex Gregory SturmerNamed on SEC filing
BR
Bob RappaportNamed on SEC filing
TE
Thomas E. JenkinsNamed on SEC filing
Funding
SEC filings, press & company announcements$4M disclosed across 4 of 6 rounds · 2017–2026
▶$2.2MraisedOct 2022 · 30 investors · BiotechnologyRule 506(b)
▶$2.2MraisedOct 2022 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alex Gregory SturmerExecutive Officer, Director
- Thomas JenkinsDirector
- James HackworthDirector
- Bob RappaportDirector
- Kathy LaPorteDirector
- Carey NgDirector
- Offering amount
- $9.1M
- Amount sold
- $2.2M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$215KraisedMar 2019 · 4 investors · BiotechnologyRule 506(b)
▶$215KraisedMar 2019 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kathy LaPorteDirector
- Alex Gregory SturmerExecutive Officer, Director
- Bob RappaportDirector
- Thomas E. JenkinsExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $215K
- Minimum investment
- $1
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$932KraisedSep 2018 · 21 investors · Other Health CareRule 506(b)
▶$932KraisedSep 2018 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kathy LaPorteDirector
- Alex Gregory SturmerExecutive Officer, Director
- Thomas E. JenkinsExecutive Officer, Director
- Bob RappaportDirector
- Offering amount
- $2.3M
- Amount sold
- $932K
- Minimum investment
- $1
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$651.8KraisedDec 2017 · 14 investors · BiotechnologyRule 506(b)
▶$651.8KraisedDec 2017 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kathy LaPorteDirector
- Alex Gregory SturmerExecutive Officer, Director
- Bob RappaportDirector
- Thomas E. JenkinsExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $651.8K
- Minimum investment
- $1
- Proceeds to insiders
- $40K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Elysium Therapeutics raised?
- Elysium Therapeutics has disclosed $4M raised across 4 of its 6 known rounds.
- Where is Elysium Therapeutics headquartered?
- Elysium Therapeutics is headquartered in Danville, US.